Phathom Pharmaceuticals, Inc. (PHAT) Reports Q2 Loss, Tops Revenue Estimates
PHATPhathom Pharmaceuticals(PHAT) ZACKS·2024-08-08 22:21

Phathom Pharmaceuticals, Inc. (PHAT) came out with a quarterly loss of 1.25pershareversustheZacksConsensusEstimateofalossof1.25 per share versus the Zacks Consensus Estimate of a loss of 1.20. This compares to loss of 0.84pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof−4.170.84 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -4.17%. A quarter ago, it was expected that this company would post a loss of 1.43 per share when it actually produced a loss of $1.42, delivering a surprise of 0.70%.Over the last four quarters, the company ...